Related News

    News

  • New TB Diagnostic Proves…

    Friday, September 3, 2010

    WHAT: A molecular test designed to easily diagnose tuberculosis (TB) and detect a drug-resistant form of the bacterium… more...

  • New Genomic Marker for…

    Monday, August 30, 2010

    It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in… more...

  • Targeted Disease Campaigns…

    Wednesday, August 18, 2010

    Global initiatives to control specific diseases, such as polio or worm diseases, in low income countries not only do… more...

  • ISU Researchers Discover…

    Wednesday, August 18, 2010

    AMES -- A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural… more...

  • A*STAR and Institut Merieux/…

    Monday, August 16, 2010

    An investment of S$3 million is being pumped into tuberculosis (TB) research by A*STAR's Singapore Immunology Network (… more...

All Related News

NewsFlash Archive

More News

Notre Dame Professor Receives $1.9 Million Grant for TB Research

| More

Friday, July 30, 2010

SOUTH BEND -- Marvin Miller, a chemistry professor at the University of Notre Dame, has received a $1.9 million grant from the National Institutes of Health for tuberculosis research.

Miller and his research group aim to understand TB's essential iron sequestration machinery and develop novel anti-TB agents.

The grant also will help the laboratory advance its current lead small molecule anti-TB agents, which are nanomolar inhibitors of drug-resistant strains, through pre-clinical development, patenting and potential partnering with industry to bring new treatments to the marketplace. The lab's TB research includes collaborations with researchers at the NIH, DowAgroScience, the Eli Lilly TB Initiative and researchers in India, China and Germany.

Miller is co-founder of PracticaChem LLP and has 20 issued patents.

 

Copyright © 1994-2010 South Bend Tribune

Source: thriveMICIHIANA.Com

0%
0 votes You need to be logged in to rate.